Location History:
- San Carlos, CA (US) (2004 - 2014)
- San Mateo, CA (US) (2010 - 2016)
Company Filing History:
Years Active: 2004-2016
Title: Roderick Tang: Innovating in the Field of Vaccines
Introduction:
Roderick Tang, a prolific inventor based in San Carlos, CA (US), has made significant contributions in the field of vaccine development and infectious diseases. With a total of 7 patents to his name, Tang's innovative work has focused on metapneumovirus strains and their applications in vaccine formulations and diagnostic methods.
Latest Patents:
Tang's latest patents revolve around the isolation of mammalian negative strand RNA viruses within the sub-family Pneumoviridae, particularly focusing on metapneumovirus strains. These patents cover genomic nucleotide sequences, chimeric and recombinant viruses, as well as vaccine formulations comprising mammalian or avian viruses. The inventions aim to enhance therapeutic methods and diagnostic approaches in combatting respiratory infections caused by metapneumoviruses.
Career Highlights:
Tang has worked with esteemed companies such as Vironovative Bv and Medimmune Vaccines, Inc., where he has honed his expertise in virology and vaccine development. His dedication to advancing medical solutions has been pivotal in driving forward the research and development of innovative vaccines.
Collaborations:
Throughout his career, Tang has collaborated with renowned experts in the field, including Ronaldus Adrianus Maria Fouchier and Bernadetta Gerarda Van Den Hoogen. These collaborations have led to groundbreaking discoveries and advancements in understanding metapneumovirus strains and their potential applications in the healthcare industry.
Conclusion:
In conclusion, Roderick Tang stands out as a visionary inventor who continues to push the boundaries of innovation in vaccine research. His patents not only showcase his technical prowess but also highlight his commitment to improving global health outcomes. Tang's contributions to the field of virology are instrumental in shaping the future of infectious disease management and prevention.